Vascular Dementia — MRCPsych Paper B MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — No, because no qualifying comorbid neurodegenerative dementia is suspected
The correct answer is E. NICE NG97 recommends considering an acetylcholinesterase inhibitor or memantine in vascular dementia only when comorbid Alzheimer's disease, Parkinson's disease dementia or dementia with Lewy bodies is suspected. The stepwise post-stroke course and absence of an antecedent progressive amnestic syndrome, parkinsonism, fluctuations or visual hallucinations make such comorbidity unsupported here. Memantine is therefore not indicated solely for his vascular dementia. Severe impairment does not create a vascular-dementia indication, so D is incorrect. Acetylcholinesterase-inhibitor intolerance supports memantine in specified circumstances in Alzheimer's disease or dementia with Lewy bodies, but not in otherwise pure vascular dementia, excluding E. Combination with donepezil is neither required nor appropriate here, excluding C.
Reference: National Institute for Health and Care Excellence. Dementia: assessment, management and support for people living with dementia and their carers (NG97), recommendation 1.5.14. 2018, current guideline page: https://www.nice.org.uk/guidance/ng97/chapter/Recommendations